Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that occurs when your body’s immune system mistakenly attacks your own healthy tissues and organs.
The Stem Cells Transplant Institute in Costa Rica, uses human umbilical cord mesenchymal stem cells (hUC-MSCs) for the treatment of systemic lupus erythematosus.
The symptoms of lupus will depend on what part of the body is being attacked but the most common symptoms include;
Normally the immune system produces antibodies which protect the body from foreign invaders such as; viruses, bacteria and germs.
In patients with SLE, the immune system malfunctions and is unable to distinguish between, these foreign invaders, and the body’s healthy tissue.
The immune system sends autoantibodies to attack and destroy the healthy tissue.
Approximately 10% of lupus patients will go on to develop the more severe systemic lupus erythematosus.
Lupus is a chronic disease that can range from mild to life threatening.
No two lupus patients are alike, and the symptoms can range from mild to severe, and temporary to permanent.
Inflammation caused by lupus can affect your joints, skin, kidneys, blood cells, brain, heart and lungs.
Some patients experience a sudden onset of symptoms, while others may have symptoms that develop slowly.
Current FDA approved treatments decrease inflammation and/or the level of autoimmune activity. Treatment will depend on the severity of the symptoms and if organs are involved.
Patients with more severe symptoms will be given corticosteroids, immunosuppressants, a monoclonal-antibody or Rituxan.
Patients are rarely cured using standard treatments and life-long treatment is often required.
Prescribed medications are costly, treatment will usually change, finding the right combination of medication can take years, and there is a risk of serious adverse events with all of the treatment options.
Physicians in China have evaluated the safety and efficacy of mesenchymal stem cell treatments in more than 200 patients unresponsive to standard treatments.
Overall results showed 75% of patients responded to treatment and some patients experienced a reduction of symptoms for up to 24 months.
In a 5 year follow up of 81 patients, 54% of patients continued to achieve complete or partial remission of the disease.
After 6 years, researchers continue to find stem cell therapy to be safe and effective with no severe treatment related adverse events.1-4
Umbilical cord stem cells have been found to be safe in patients with immune disease.
According to ClinicalTrials.gov (https://clinicaltrials.gov) there are currently 8 studies being conducted using hUC-MSCs in patients with SLE and an additional 39 clinical trials in other related autoimmune diseases.
Image from Clinicaltrials.gov 3.20.19
The Stem Cells Transplant Institute recommends the use of hUC-MSCs for the treatment of Lupus and SLE. For optimal results we recommend a 2-day treatment that will include:
We use only umbilical cord stem cells that are derived exclusively from umbilical cord donations.
The umbilical cord stem cells from are collected after informed consent has been given by the parent, or parents, and only after the delivery of the baby.
The collection follows strict ethical protocols ensuring the stem cells are from safe, reliable sources using a non-invasive, simple and painless procedure.
Once collected, the cord blood is then screened for disease.
Costa Rica has one of the best healthcare systems in world and is ranked among the highest for medical tourism.
Using the most advanced technologies, the team of experts at The Stem Cells Transplant Institute believe in the potential of stem cell therapy for the treatment of autoimmune diseases.
We are committed to providing personalized service and the highest quality of care to every patient.